Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

Sponsor
Amgen (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT02808403
Collaborator
(none)
6,000
139
81.2
43.2
0.5

Study Details

Study Description

Brief Summary

The purpose of this post-marketing survey is to obtain real-world information on the safety and effectiveness of evolocumab in Japan.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Detailed Description

The objectives of study are to 1) determine the incidence of adverse events and adverse drug reactions among patients receiving evolocumab for up to 2 years, and 2) identify and describe patient characteristics (e.g. demographics, medical history) associated with the safety and effectiveness of evolocumab therapy for the patients with Familial Hypercholesterolemia (Heterozygous or Homozygous) and Hypercholesterolemia in Japan

Study Design

Study Type:
Observational
Actual Enrollment :
6000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab (AMG 145) in Japan
Actual Study Start Date :
Jun 24, 2016
Anticipated Primary Completion Date :
Oct 31, 2022
Anticipated Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Evolocumab exposed

Patients for whom evolocumab is prescribed. Dosage, period (start/end date), frequency of injection (Every 2 weeks (Q2W), Every 4 weeks (Q4W)), drug withdrawal (Yes or No, date, reason) and injection site (upper arm, abdomen, thigh) of evolocumab will be collected.

Other: No intervention
No intervention; observation of routine medical care

Outcome Measures

Primary Outcome Measures

  1. Incidence of adverse events and adverse drug reactions [2 years]

    The incidence of adverse events and drug reactions will be described using the same units (events per 1000 person-years). Adverse events (including seriousness and causal relations to drug or device), inclusive of reaction at local injection sites, and other safety information (e.g. overdose, lack of effectiveness, pregnancy and lactation with or without adverse event) will be described.

  2. Laboratory values for LDL-C [2 years]

  3. Laboratory values for HDL-C [2 years]

  4. Laboratory values for total cholesterol [2 years]

  5. Laboratory values for triglycerides [2 years]

  6. Laboratory values for Apolipoprotein (Apo) A1 [2 years]

    This will be measured if feasible.

  7. Laboratory values for Apolipoprotein (Apo) Apo B [2 years]

    This will be measured if feasible.

  8. Laboratory values for Apolipoprotein (Apo) Apo E [2 years]

    This will be measured if feasible.

  9. Laboratory values for lipoprotein(a) [2 years]

    This will be measured if feasible.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients for whom evolocumab is prescribed at participating medical institutions in accordance with the approved Japan prescribing information (i.e., those with Familial Hypercholesterolemia (Heterozygous or Homozygous and Hypercholesterolemia who have high risk factors for cardiovascular event and do not respond sufficiently to HMGCoA reductase inhibitor (statin) for hypercholesterolemia).
Exclusion Criteria:
  • No exclusion criteria are applied.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Research Site Ichinomiya city Aichi Prefecture Japan 491-0911
2 Research Site Ichinomiya city Aichi Prefecture Japan 494-0001
3 Research Site Inuyama city Aichi Prefecture Japan 484-0074
4 Research Site Kasugai city Aichi Prefecture Japan 487-0016
5 Research Site Komaki city Aichi Prefecture Japan 485-0000
6 Research Site Nagoya city Aichi Prefecture Japan 454-0933
7 Research Site Nagoya city Aichi Prefecture Japan 455-8530
8 Research Site Nagoya city Aichi Prefecture Japan 457-0047
9 Research Site Nagoya city Aichi Prefecture Japan 457-8511
10 Research Site Nagoya city Aichi Prefecture Japan 465-0094
11 Research Site Nagoya city Aichi Prefecture Japan 466-0815
12 Research Site Nagoya city Aichi Prefecture Japan 466-8560
13 Research Site Tsushima city Aichi Prefecture Japan 496-8537
14 Research Site Akita city Akita Prefecture Japan 010-1423
15 Research Site Yuzawa city Akita Prefecture Japan 012-0037
16 Research Site Asahi city Chiba Prefecture Japan 289-2511
17 Research Site Chiba City Chiba Prefecture Japan 260-8677
18 Research Site Chosei Gun Chiba Prefecture Japan 297-0203
19 Research Site Ichihara city Chiba Prefecture Japan 299-0111
20 Research Site Ichikawa city Chiba Prefecture Japan 272-0103
21 Research Site Kisarazu city Chiba Prefecture Japan 292-0038
22 Research Site Matsudo city Chiba Prefecture Japan 270-2232
23 Research Site Matsuyama city Ehime Prefecture Japan 791-8026
24 Research Site Fukuoka city Fukuoka Prefecture Japan 810-0001
25 Research Site Fukuoka city Fukuoka Prefecture Japan 812-8582
26 Research Site Fukuoka city Fukuoka Prefecture Japan 815-8588
27 Research Site Itoshima city Fukuoka Prefecture Japan 819-1104
28 Research Site Kitakyushu city Fukuoka Prefecture Japan 802-0001
29 Research Site Kitakyushu city Fukuoka Prefecture Japan 807-8556
30 Research Site Omuta city Fukuoka Prefecture Japan 837-0916
31 Research Site Futaba gun Fukushima Prefecture Japan 979-0403
32 Research Site Iwaki city Fukushima Prefecture Japan 973-8555
33 Research Site Koriyama city Fukushima Prefecture Japan 963-8501
34 Research Site Kani city Gifu Prefecture Japan 509-0214
35 Research Site Mino city Gifu Prefecture Japan 501-3732
36 Research Site Nagahama city Gifu Prefecture Japan 526-8580
37 Research Site Fujioka city Gunma Prefecture Japan 375-0024
38 Research Site Kiryu city Gunma Prefecture Japan 376-0011
39 Research Site Takasaki city Gunma Prefecture Japan 370-3513
40 Research Site Takasaki Gunma Prefecture Japan 370-3513
41 Research Site Fukuyama city Hiroshima Prefecture Japan 720-0001
42 Research Site Higashihiroshima city Hiroshima Prefecture Japan 739-2104
43 Research Site Hiroshima city Hiroshima Prefecture Japan 734-8551
44 Research Site Onomichi city Hiroshima Prefecture Japan 722-8508
45 Research Site Iwamizawa city Hokkaido Japan 068-8555
46 Research Site Sapporo city Hokkaido Japan 002-8072
47 Research Site Sapporo city Hokkaido Japan 060-0031
48 Research Site Sapporo city Hokkaido Japan 062-0003
49 Research Site Sapporo city Hokkaido Japan 065-0027
50 Research Site Himeji city Hyogo Prefectural Japan 671-1227
51 Research Site Kobe city Hyogo Prefectural Japan 651-1145
52 Research Site Kobe city Hyogo Prefectural Japan 651-1351
53 Research Site Sanda city Hyogo Prefectural Japan 669-1321
54 Research Site Kobe city Hyogo Prefecture Japan 651-1321
55 Research Site Kobe city Hyogo Prefecture Japan 654-0155
56 Research Site Kobe city Hyogo Prefecture Japan 658-0032
57 Research Site Kobe city Hyogo Prefecture Japan 658-0072
58 Research Site Higashiibaraki Gun Ibaraki Prefecture Japan 311-3193
59 Research Site Hitachi city Ibaraki Prefecture Japan 317-0077
60 Research Site Mito city Ibaraki Prefecture Japan 310-0004
61 Research Site Kahoku gun Ishikawa Prefecture Japan 920-0293
62 Research Site Kanazawa city Ishikawa Prefecture Japan 920-0353
63 Research Site Kanazawa city Ishikawa Prefecture Japan 920-8530
64 Research Site Kanazawa city Ishikawa Prefecture Japan 920-8641
65 Research Site Kanazawa city Ishikawa Prefecture Japan 921-8035
66 Research Site Uchinada Ishikawa Prefecture Japan 920-0293
67 Research Site Kitakami city Iwate Prefecture Japan 024-0021
68 Research Site Morioka city Iwate Prefecture Japan 020-0066
69 Research Site Kita gun Kagawa Prefecture Japan 761-0793
70 Research Site Sakaide City Kagawa Prefecture Japan 762-8550
71 Research Site Zentsuji City Kagawa Prefecture Japan 765-8507
72 Research Site Kagoshima city Kagoshima Prefecture Japan 890-8760
73 Research Site Kagoshima city Kagoshima Prefecture Japan 892-0828
74 Research Site Kanoya city Kagoshima Prefecture Japan 893-0013
75 Research Site Fujisawa city Kanagawa Prefecture Japan 251-0003
76 Research Site Kawasaki city Kanagawa Prefecture Japan 210-0013
77 Research Site Kawasaki city Kanagawa Prefecture Japan 214-0014
78 Research Site Miura city Kanagawa Prefecture Japan 238-0101
79 Research Site Yokohama city Kanagawa Prefecture Japan 231-0806
80 Research Site Yokohama city Kanagawa Prefecture Japan 236-0037
81 Research Site Yokohama city Kanagawa Prefecture Japan 247-8581
82 Research Site Yokosuka city Kanagawa Prefecture Japan 238-8558
83 Research Site Yokosuka city Kanagawa Prefecture Japan 238-8567
84 Research Site Yokosuka city Kanagawa Prefecture Japan 240-0195
85 Research Site Kumamoto city Kumamoto Prefecture Japan 860-8515
86 Research Site Kumamoto city Kumamoto Prefecture Japan 860-8556
87 Research Site Yamaga city Kumamoto Prefecture Japan 861-0517
88 Research Site Kyoto city Kyoto Prefecture Japan 602-8566
89 Research Site Kyoto city Kyoto Prefecture Japan 615-0812
90 Research Site Maizuru city Kyoto Prefecture Japan 625-8585
91 Research Site Uji city Kyoto Prefecture Japan 611-0041
92 Research Site Yosa Gun Kyoto Prefecture Japan 629-2261
93 Research Site Ise city Mie Prefecture Japan 516-8512
94 Research Site Tsu city Mie Prefecture Japan 514-8507
95 Research Site Sendai city Miyagi Prefecture Japan 980-8574
96 Research Site Miyazaki city Miyazaki Prefecture Japan 880-0924
97 Research Site Matsumoto city Nagano Prefecture Japan 390-8621
98 Research Site Niigata city Niigata Prefecture Japan 950-0165
99 Research Site Oita city Oita Prefecture Japan 879-7761
100 Research Site Okayama city Okayama Prefecture Japan 700-0804
101 Research Site Okayama city Okayama Prefecture Japan 700-8505
102 Research Site Okayama city Okayama Prefecture Japan 700-8558
103 Research Site Okayama city Okayama Prefecture Japan 703-8265
104 Research Site Izumisano city Osaka Prefecture Japan 598-8577
105 Research Site Kawachinagano City Osaka Prefecture Japan 586-8521
106 Research Site Osaka city Osaka Prefecture Japan 533-0003
107 Research Site Osaka city Osaka Prefecture Japan 537-8511
108 Research Site Osaka city Osaka Prefecture Japan 543-0011
109 Research Site Suita city Osaka Prefecture Japan 564-0013
110 Research Site Suita city Osaka Prefecture Japan 565-0871
111 Research Site Suita city Osaka Prefecture Japan 565-8565
112 Research Site Takaishi city Osaka Prefecture Japan 592-0014
113 Research Site Takatsuki city Osaka Prefecture Japan 569-8585
114 Research Site Saga city Saga Prefecture Japan 840-0862
115 Research Site Taku city Saga Prefecture Japan 844-0002
116 Research Site Ageo city Saitama Prefecture Japan 362-8588
117 Research Site Koshigaya city Saitama Prefecture Japan 343-8555
118 Research Site Saitama city Saitama Prefecture Japan 330-0855
119 Research Site Saitama city Saitama Prefecture Japan 339-0033
120 Research Site Moriyama city Shiga Prefecture Japan 524-8524
121 Research Site Hamada city Shimane Prefecture Japan 697-8511
122 Research Site Nikko city Tochigi Prefecture Japan 321-2593
123 Research Site Tokushima city Tokushima Prefecture Japan 770-8503
124 Research Site Higashikurume city Tokyo Prefecture Japan 203-0043
125 Research Site Shinagawa City Tokyo Prefecture Japan 141-0001
126 Research Site Chuoku Tokyo Japan 104-8560
127 Research Site Hachioji city Tokyo Japan 192-0918
128 Research Site Hachioji city Tokyo Japan 193-0998
129 Research Site Kodaira city Tokyo Japan 187-0003
130 Research Site Ota ku Tokyo Japan 146-8531
131 Research Site Shibuyaku Tokyo Japan 150-8935
132 Research Site Sinagawa Ku Tokyo Japan 140-8522
133 Research Site Taitoku Tokyo Japan 111-0053
134 Research Site Toshimaku Tokyo Japan 171-0014
135 Research Site Gobo city Wakayama Prefecture Japan 644-0002
136 Research Site Shingu city Wakayama Prefecture Japan 647-0072
137 Research Site Wakayama city Wakayama Prefecture Japan 640-8505
138 Research Site Wakayama city Wakayama Prefecture Japan 640-8558
139 Research Site Kofu city Yamanashi Prefecture Japan 400-8506

Sponsors and Collaborators

  • Amgen

Investigators

  • Study Director: MD, Amgen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amgen
ClinicalTrials.gov Identifier:
NCT02808403
Other Study ID Numbers:
  • 20140409
First Posted:
Jun 21, 2016
Last Update Posted:
May 11, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 11, 2022